Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients with Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.
Recruiting now
Conditions studied: Glaucoma
In brief
The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.
Key facts
- Study ID
- NCT06227611
- Run by
- Fondazione G.B. Bietti, IRCCS
- People needed
- 16
- Starts
- 2021-05-04
- Expected to finish
- 2025-05-04
- Last updated by the study team
- 2025-02-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- glaucoma patients with glaucomatous optic nerve head defect and reduced ganglion cell layer thickness
You may not qualify if…
- age<18 years
- unable to read, understand and sign the written informed consent
- unable to perform visual field test
- advanced glaucoma with C/D>0.7
- other causes of optic neuropathies
- retinal or macular diseases
- lens or corneal opacities
- spherical refractive defect >± 6D
- cylindric refractive defect >± 3D
Where it is running
- IRCCS-Fondazione GB Bietti — Rome, Italy (enrolling)
- University of Rome Tor Vergata — Rome, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.